"Eradication is an unforgiving goal," says Emory's Walt Orenstein, MD. "A handful of cases means you've failed."
Saudi Arabia's Ministry of Health (MOH) today announced two new MERS-CoV cases, both of them involving men who had primary exposure to the virus, meaning they didn't contract their infections from another person.
A trial of the antiviral drug favipiravir in Ebola patients during Sierra Leone's outbreak suggests that it can reduce viral load, improve clinical symptoms, increase the survival rate, and prolong survival time, Chinese and African researchers reported yesterday in Clinical Infectious Diseases (CID).
Deep genome sequencing of two autopsy specimens from people who died in a 1979 accident at a Soviet anthrax production facility revealed that the Bacillus anthracis is similar to a wild type strain from Russia and shows no evidence of genetic manipulation for drug resistance or other characteristics.
SAB Biotherapeutics, Inc., of Sioux Falls, S.D., announced today that its experimental human antibody treatment for MERS-CoV—called SAB-301—has entered human trials, the first potential treatment for the disease to do so.
Michigan health officials recently announced two variant H3N2 (H3N2v) influenza illnesses in Muskegon County residents who exhibited swine at the Muskegon County fair in late July. The cases appear to be the nation's first for 2016.
An outbreak of an especially large and severe enterovirus A71 (EV-A71) outbreak in kids younger than 10 in Spain's Catalonia region that began in the middle of April has so far sickened 87, with 22 still in the hospital, the European Centre for Disease Prevention and Control (ECDC) said today in a risk assessment.
Only a few new yellow fever cases have been reported in Angola in the past week, but the mostly urban epidemic is still a big concern because of persistent transmission in seven provinces and expansion to new ones, the World Health Organization (WHO) said in its weekly update today.
As part of the effort to preserve medically important antimicrobials, pharmaceutical companies will henceforward be required to report sales of antimicrobial drugs for food animals by species, not just overall totals, the US Food and Drug Administration (FDA) announced yesterday.
Takeda Pharmaceutical Company today announced a $38 million grant from the Bill and Melinda Gates Foundation, part of a partnership to develop a safe, effective, and affordable Sabin-strain inactivated polio vaccine (IPV) for developing countries.
